Covid-19 roundup: EMA recommends Moderna vaccine for authorization; Woodcock returns to FDA as Hahn advisor — reports
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine.
Regulators came to the decision Wednesday morning, marking the second vaccine given authorization in Europe following Pfizer and BioNTech. EMA had previously scheduled a deadline for Jan. 12 to reach a decision.
The ball will now head to the European Commission’s court, which has the final say on any opinions given by the EMA and CHMP. Should the body give it the thumbs up — a virtual certainty — the EU would become the fourth to OK the vaccine, following authorizations in the US, Canada and Israel.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters